Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes.
D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors* / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007945:Leukemia, Lymphoid / Q000201:enzymology*; D008214:Lymphocytes / Q000201:enzymology*; D008970:Molecular Weight; D009711:Nucleotides / Q000378:metabolism; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012294:Rifamycins / Q000378:metabolism / Q000494:pharmacology*; D014316:Tritium
D009711:Nucleotides; D012334:RNA, Neoplasm; D012294:Rifamycins; D014316:Tritium; D012321:DNA-Directed RNA Polymerases